Health News Releases

August 30, 2019 17:20

Anniversary of the pivotal RE-LY® trial marks a decade of innovation for stroke prevention in AF patients

Boehringer Ingelheim today announces the ten-year anniversary of the RE-LY® trial publication[1-3] recognising the contribution made in the decade since by patients, healthcare professionals (HCPs) an

August 29, 2019 16:29

PCI Strengthens Position in Europe with Investment in Ireland

PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and e

August 29, 2019 11:01

The Mary Kay FoundationSM and UT Southwestern Partner to End Cancers Impacting Women Globally

The Mary Kay FoundationSM, a decades-long leader in the charge to eliminate cancers affecting women, recently announced a $500,000 grant to fund a groundbreaking global fellowship program with long-ti

August 29, 2019 10:45

GABA Resurgence: Pharma Foods International Releases Study Proving Unexpected Benefit to Muscle Growth From a Valued Amino Acid

Pharma Foods International Co. Ltd. has made available for publication its first-ever study proving that supplementing a post-exercise whey protein regimen with their naturally-produced flagship produ

August 27, 2019 16:11

Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, to Reduce Hyperoxia in Critically Ill Patients

Masimo (NASDAQ: MASI) announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monit

August 23, 2019 11:48

Registration for 2020 World Patient Safety, Science & Technology Summit Now Open

Registration for the Patient Safety Movement’s (PSMF) 2020 World Patient Safety, Science & Technology Summit is now open. Co-convened with the International Society for Quality in Health Care (ISQua),

August 20, 2019 16:00

Sustainable Manufacturing Practices Needed to Combat Growing Antimicrobial Resistance

Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institute of Technology - Delhi, organized a workshop on ‘Sustainability Through Excelle

August 19, 2019 11:55

Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award

The Anesthesia Patient Safety Foundation (APSF), in partnership with the Patient Safety Movement Foundation (PSMF), is now accepting proposals for the Patient Safety Curriculum Award. The $100,000 awa

August 19, 2019 10:41

2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy

The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective a

August 14, 2019 15:37

Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon

Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus

August 14, 2019 11:45

Terns Pharmaceuticals Announces Positive Interim Results From Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced the

August 13, 2019 09:48

Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for various types

August 12, 2019 11:43

Mary Kay Reveals Research on Skin Barrier Function and Facial Redness at the Chinese Association of Integrative Medicine Meeting

As one of the world’s leading skincare innovators in the direct selling and cosmetic industries, Mary Kay continued its decades-long commitment to skin science research by revealing the results of a s

August 08, 2019 09:59

Study Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring

Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and bloo

August 06, 2019 10:59

SpeeDx Pty. Ltd. Raises $15 Million From U.S. Investment Partnership

SpeeDx Pty. Ltd., the developer of transformative new molecular diagnostic solutions, today announced it had raised up to US $10 million in additional equity investment from US-based Northpond Venture

August 06, 2019 10:18

Masimo Announces CE Marking of Neonatal Indication for Noninvasive, Continuous Hemoglobin Monitoring (SpHb®)

Masimo (NASDAQ: MASI) announced today the CE marking of SpHb®, noninvasive and continuous hemoglobin monitoring, for neonatal and infant patients (< 3 kg). With this clearance, the benefits of SpHb ar

August 05, 2019 09:29

Updated real-world data shows Giotrif®/Gilotrif® (afatinib) followed by osimertinib provided a median overall survival of up to almost four years in patients with EGFR Del19 and T790M mutation-positive NSCLC

Boehringer Ingelheim today announced updated, interim analysis results from the GioTag study, showing that initiating treatment with afatinib followed by osimertinib provided an overall survival (OS)

August 02, 2019 18:58

Alvogen and Lotus Announce First to Launch Generic Version of Navelbine® Softgel Capsule in Europe

Alvogen today announced that its subsidiary Lotus Pharmaceuticals has launched Vinorelbine 20, 30 and 80mg soft capsules in Europe. The product is the generic version of Pierre Fabre Médicament’s Nave

August 02, 2019 18:15

Takeda Announces FY2019 Key Performance Indicators Aligned with Shareholder Value Creation and Focused on Successful Integration

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO: 4502/NYSE: TAK) today announces that the Takeda Board of Directors has approved key performance indicators (KPIs) to be included in both the co

August 02, 2019 17:16

Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year

Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): Underlying Revenue declined -0.8% vs FY2018 Q1 pro-forma revenue[1] · Takeda’s 14 global brands, with an aggregate revenue of 270.2

August 01, 2019 18:59

Biological E and GVK BIO Announce Strategic R&D Partnership

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets c

July 31, 2019 17:33

Renowned Nutrigenomics Authority Affirms the Exceptional Immunobiotic Benefits of House Wellness Foods’ Key Ingredient, HK L-137

Lactobacillus HK L-137, the primary constituent of House Wellness Foods Immuno-LP20, has received one of its strongest endorsements to date from nutritional biochemist Dr. Christine Houghton, Ph.D.,BS

July 30, 2019 22:05

The Healthcare+ Expo Taiwan Continues to Lead a Medical Innovation Hub With Its Strength in Digital Health, Health Tech and Medicine

Following the success last year, the Healthcare+ Expo sees a rapid growth in size and significance of procurement, networking and marketing. The Expo is now regarded as a primary event in Asia, attrac

July 30, 2019 11:07

NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS

NEC Corporation (NEC; TOKYO: 6701) today announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight ag

July 29, 2019 16:00

Philanthropist Tej Kohli Pledges $2 Million Gift to Champion Biotech Solutions for Eliminating Corneal Blindness Worldwide By 2030

Tej Kohli, a London-based billionaire who made his fortune during the dotcom boom selling e-commerce payments software, has pledged $2 million to Massachusetts Eye and Ear in Boston to fund innovation

News by Region

News by Industry